$AXGN
Axogen, Inc. Stock $axgn

$axgn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000080592823000020 Filed on March 14, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$36.66M	$36.16M	$138.6M
YoY Change	18.24%	14.67%	8.81%
Cost Of Revenue	$6.709M	$6.957M	$24.15M
YoY Change	20.97%	13.94%	5.3%
Gross Profit	$29.96M	$29.21M	$114.4M
YoY Change	17.65%	14.85%	9.59%
Gross Profit Margin	81.7%	80.76%	82.58%
Selling, General & Admin	$30.62M	$28.00M	$117.0M
YoY Change	0.36%	14.39%	10.71%
% of Gross Profit	102.21%	95.88%	102.23%
Research & Development	$6.679M	$6.811M	$27.16M
YoY Change	6.44%	8.08%	12.33%
% of Gross Profit	22.3%	23.32%	23.73%
Depreciation & Amortization	$709.0K	$712.0K	$2.827M
YoY Change	0.71%	-0.56%	3.9%
% of Gross Profit	2.37%	2.44%	2.47%
Operating Expenses	$37.30M	$34.82M	$144.1M
YoY Change	1.4%	13.09%	11.01%
Operating Profit	-$7.341M	-$5.608M	-$29.71M
YoY Change	-35.15%	4.76%	16.88%
Interest Expense	$16.00K	$326.0K	$624.0K
YoY Change	-95.48%	56.73%	-53.98%
% of Operating Profit
Other Income/Expense, Net	$267.0K	-$133.0K	$759.0K
YoY Change	-272.26%	-5.67%	-148.37%
Pretax Income	-$7.074M	-$5.415M	-$28.95M
YoY Change	-38.35%	2.44%	7.27%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$7.074M	-$5.415M	-$28.95M
YoY Change	-38.35%	2.44%	7.27%
Net Earnings / Revenue	-19.29%	-14.97%	-20.89%
Basic Earnings Per Share	-$0.17		-$0.69
Diluted Earnings Per Share	-$0.17	-$0.13	-$0.69
COMMON SHARES
Basic Shares Outstanding	42.60M shares	42.29M shares	42.08M shares
Diluted Shares Outstanding	42.57M shares		42.08M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.87M	$48.79M	$48.79M
YoY Change	-43.83%	-41.98%	-41.98%
Cash & Equivalents	$7.707M	$15.28M	$15.28M
Short-Term Investments	$30.16M	$33.51M	$33.51M
Other Short-Term Assets	$8.705M	$8.195M	$8.195M
YoY Change	-3.99%	1.35%	1.35%
Inventory	$19.85M	$18.91M	$18.91M
Prepaid Expenses
Receivables	$22.28M	$22.19M	$22.19M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$88.70M	$98.08M	$98.08M
YoY Change	-21.14%	-22.81%	-22.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$96.92M	$93.66M	$93.66M
YoY Change	17.67%	48.95%	19.9%
Goodwill
YoY Change
Intangibles	$3.858M	$3.649M
YoY Change	20.94%	27.63%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$100.8M	$97.31M	$97.31M
YoY Change	17.8%	20.18%	20.18%
TOTAL ASSETS
Total Short-Term Assets	$88.70M	$98.08M	$98.08M
Total Long-Term Assets	$100.8M	$97.31M	$97.31M
Total Assets	$189.5M	$195.4M	$195.4M
YoY Change	-4.32%	-6.07%	-6.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.19M	$8.964M	$8.964M
YoY Change	-3.28%	51.34%	51.34%
Accrued Expenses	$1.043M	$1.303M	$14.78M
YoY Change	-49.49%	-92.9%	-19.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.000K	$7.000K	$7.000K
YoY Change	-12.5%	-22.22%	-22.22%
Total Short-Term Liabilities	$21.24M	$23.75M	$23.75M
YoY Change	-7.44%	-2.22%	-2.22%
LONG-TERM LIABILITIES
Long-Term Debt	$45.93M	$45.71M	$45.73M
YoY Change	1.98%	1.99%	2.02%
Other Long-Term Liabilities	$24.78M	$24.91M	$24.91M
YoY Change	-5.38%		-5.51%
Total Long-Term Liabilities	$45.93M	$45.71M	$70.64M
YoY Change	1.98%	1.99%	-0.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.24M	$23.75M	$23.75M
Total Long-Term Liabilities	$45.93M	$45.71M	$70.64M
Total Liabilities	$91.96M	$94.39M	$94.39M
YoY Change	-2.35%	-1.14%	-1.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$266.7M	-$259.6M
YoY Change	10.14%	12.55%
Common Stock	$364.2M	$360.6M
YoY Change	5.26%	5.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$97.51M	$101.0M	$101.0M
YoY Change
Total Liabilities & Shareholders Equity	$189.5M	$195.4M	$195.4M
YoY Change	-4.32%	-6.07%	-6.07%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$7.074M	-$5.415M	-$28.95M
YoY Change	-38.35%	2.44%	7.27%
Depreciation, Depletion And Amortization	$709.0K	$712.0K	$2.827M
YoY Change	0.71%	-0.56%	3.9%
Cash From Operating Activities	-$7.423M	$1.362M	-$16.07M
YoY Change	-32.83%	-189.96%	19.85%
INVESTING ACTIVITIES
Capital Expenditures	$4.304M	$6.769M	$20.08M
YoY Change	-14.55%	-193.69%	-27.81%
Acquisitions
YoY Change
Other Investing Activities	$3.771M	$5.560M	$18.05M
YoY Change	-332.2%	-187.42%	279.98%
Cash From Investing Activities	-$786.0K	-$1.209M	-$3.200M
YoY Change	-89.15%	-91.1%	-86.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$633.0K	813.0K	$1.794M
YoY Change	566.32%	-22.05%	-91.23%
NET CHANGE
Cash From Operating Activities	-$7.423M	1.362M	-$16.07M
Cash From Investing Activities	-$786.0K	-1.209M	-$3.200M
Cash From Financing Activities	$633.0K	813.0K	$1.794M
Net Change In Cash	-$7.576M	966.0K	-$17.47M
YoY Change	-58.37%	-106.87%	5.24%
FREE CASH FLOW
Cash From Operating Activities	-$7.423M	$1.362M	-$16.07M
Capital Expenditures	$4.304M	$6.769M	$20.08M
Free Cash Flow	-$11.73M	-$5.407M	-$36.14M
YoY Change	-27.11%	-194.68%	-12.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000805928
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2022	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2020	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2022Q4	us-gaap	Government Assistance Statement Of Financial Position Extensible Enumeration GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Government Assistance Statement Of Financial Position Extensible Enumeration GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilityCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20221231#LeaseLiabilitiesNoncurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-36046
CY2022	dei	Entity Registrant Name EntityRegistrantName	AXOGEN, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	13631 Progress Blvd., Suite 400
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Alachua
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1301878
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32615
CY2022	dei	City Area Code CityAreaCode	386
CY2022	dei	Local Phone Number LocalPhoneNumber	462-6800
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2022	dei	Trading Symbol TradingSymbol	AXGN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	221521729	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42601918	shares
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2022	dei	Auditor Location AuditorLocation	Miami, Florida
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15284000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32756000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	33505000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	51330000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	650000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	276000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22186000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18158000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	18905000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	16693000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1944000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1861000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	98075000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	127049000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	79294000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	62923000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14369000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15193000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3649000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2859000	usd
CY2022Q4	us-gaap	Assets Assets	195387000	usd
CY2021Q4	us-gaap	Assets Assets	208024000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22443000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22459000	usd
CY2022Q4	axgn	Lease Liability Current LeaseLiabilityCurrent	1310000	usd
CY2021Q4	axgn	Lease Liability Current LeaseLiabilityCurrent	1834000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23753000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24293000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	45712000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	44821000	usd
CY2022Q4	axgn	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	20405000	usd
CY2021Q4	axgn	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	20798000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4518000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5562000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	94388000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	95474000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42445517	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42445517	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41736950	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41736950	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	424000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	417000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	360155000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	342765000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-259580000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230632000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	100999000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	112550000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195387000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	208024000	usd
CY2022	us-gaap	Revenues Revenues	138584000	usd
CY2021	us-gaap	Revenues Revenues	127358000	usd
CY2020	us-gaap	Revenues Revenues	112300000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24147000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22931000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21581000	usd
CY2022	us-gaap	Gross Profit GrossProfit	114437000	usd
CY2021	us-gaap	Gross Profit GrossProfit	104427000	usd
CY2020	us-gaap	Gross Profit GrossProfit	90719000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	80228000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	73328000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69659000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27158000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24177000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17846000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36758000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32338000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26396000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	144144000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	129843000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	113901000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-29707000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-25416000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23182000	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	569000	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	93000	usd
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	605000	usd
CY2022	us-gaap	Interest Expense InterestExpense	624000	usd
CY2021	us-gaap	Interest Expense InterestExpense	1356000	usd
CY2020	us-gaap	Interest Expense InterestExpense	1054000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1044000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-28000	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-117000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-230000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-278000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-38000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	759000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1569000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-604000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28948000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26985000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42083125	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42083125	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42083125	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42083125	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41214889	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41214889	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39966937	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39966937	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	132153000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8470000	usd
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	670000	usd
CY2020	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	3300000	usd
CY2020	axgn	Stock Issued During Period Settlement Of Warrants And Rights Value StockIssuedDuringPeriodSettlementOfWarrantsAndRightsValue	3682000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123149000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10919000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2021	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	5467000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26985000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	112550000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15591000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2022	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1806000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28948000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	100999000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28948000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26985000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2827000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2744000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1530000	usd
CY2022	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	1761000	usd
CY2021	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	1795000	usd
CY2020	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	1777000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	265000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	891000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	831000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	232000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	612000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-41000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-105000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1769000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	3314000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	2242000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	228000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-68000	usd
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1044000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-28000	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-117000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	15591000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10919000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8470000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4639000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	499000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	635000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3656000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7478000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	910000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	84000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2435000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2524000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	660000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-270000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4958000	usd
CY2022	axgn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	1841000	usd
CY2021	axgn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	463000	usd
CY2020	axgn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	1086000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000	usd
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-12000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16066000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13405000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9626000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20078000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27811000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21905000	usd
CY2022	axgn	Proceeds From Grantors Investing Activities ProceedsFromGrantorsInvestingActivities	0	usd
CY2021	axgn	Proceeds From Grantors Investing Activities ProceedsFromGrantorsInvestingActivities	950000	usd
CY2020	axgn	Proceeds From Grantors Investing Activities ProceedsFromGrantorsInvestingActivities	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	39247000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	68699000	usd
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	77806000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	57300000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	72500000	usd
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	83440000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1175000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	589000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	692000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23649000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16963000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	35000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7820000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	7820000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3500000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	642000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15000	usd
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1806000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5467000	usd
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3300000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	670000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1794000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20452000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40474000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17472000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16602000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13885000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39007000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55609000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41724000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21535000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39007000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55609000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	495000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	822000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	866000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1420000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1077000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	5250000	usd
CY2022	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	0	usd
CY2021	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	3037000	usd
CY2020	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	2563000	usd
CY2022	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	1018000	usd
CY2021	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	1375000	usd
CY2020	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	14259000	usd
CY2022	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	0	usd
CY2021	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	0	usd
CY2020	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	182000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	299000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	418000	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	Nature of Business <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axogen, Inc. (together with its wholly-owned subsidiaries, the “Company”) was incorporated in Minnesota and is the leader in the science, development and commercialization of the technologies used for the peripheral nerve regeneration and repair. The Company's products include Avance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nerve Graft, Axoguard Nerve Connector</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axoguard Nerve Protector</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axoguard Nerve Cap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axotouch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Two-Point Discriminator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is headquartered in Florida. The Company has processing, warehousing, and distribution facilities in Texas and Ohio.</span>The Company manages its operations as a single operating segment. Substantially all of the Company's assets are maintained in the United States. The Company derives substantially all of its revenues from sales to customers in the United States.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates affecting the amounts reported or disclosed in the consolidated financial statements include the realizable value of inventories, the valuation of stock-based compensation and the valuation of derivative instruments and the fair value of debt instruments. Other estimates that affect the amounts reported or disclosed in the consolidated financial statements include the allowance for doubtful accounts, the useful life and recoverability of long-lived assets, incremental borrowing rates for operating leases, accounting for income taxes including the realizability of deferred tax assets and the related valuation allowance. The Company bases its estimates on historical and anticipated results, trends, and various other assumptions that management believes are reasonable under the circumstances, including assumptions as to future events. Actual results may differ from those estimates.</span></div>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain prior year amounts have been reclassified for consistency with the current year presentation. Specifically, finance lease right-of-use assets which were presented separately in 2021, and are now included in property and equipment. In addition, the debt derivative liability was included in net operating loss carryforwards in deferred assets in 2021, it is presented separately as debt derivative liability in deferred tax assets. See Note 12 - Income Taxes.
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	15034000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15284000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32756000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21535000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39007000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions and trade receivables. </span></div>The Company's products are sold on an uncollateralized basis and on credit terms.
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4869000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	18905000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	6155000	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4277000	usd
CY2022	axgn	Contributions To Charitable Organization ContributionsToCharitableOrganization	700000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	16693000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1769000	usd
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	158000	usd
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	1164000	usd
CY2020	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	628000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	3314000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	2242000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12651000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11011000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1026000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	813000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5228000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	131000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	110000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	89590000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	70536000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	10296000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	7614000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	79294000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	62923000	usd
CY2022Q4	us-gaap	Government Assistance Amount Cumulative GovernmentAssistanceAmountCumulative	1188000	usd
CY2021Q4	us-gaap	Government Assistance Amount Cumulative GovernmentAssistanceAmountCumulative	1188000	usd
CY2022	us-gaap	Depreciation Depreciation	2827000	usd
CY2021	us-gaap	Depreciation Depreciation	2744000	usd
CY2020	us-gaap	Depreciation Depreciation	1530000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3649000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3945000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4893000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1635000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3258000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3570000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2484000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5284000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1635000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2859000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	265000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22459000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8964000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5923000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4520000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6863000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8959000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	9673000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22443000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	20000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	usd
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4077000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	4326000	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	2777000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	72000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000	usd
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	116000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1241000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	744000	usd
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	18000	usd
CY2022	us-gaap	Lease Cost LeaseCost	5412000	usd
CY2021	us-gaap	Lease Cost LeaseCost	5104000	usd
CY2020	us-gaap	Lease Cost LeaseCost	2936000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14369000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15193000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1303000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1825000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20387000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20794000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	41000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	42000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1058
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1032
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1191
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0723
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26985000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year One LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearOne	3519000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Two LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearTwo	3297000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Three LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearThree	3336000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Four LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearFour	3348000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Five LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearFive	2921000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid After Year Five LesseeOperatingAndFinancingLeaseLiabilityToBePaidAfterYearFive	20931000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability To Be Paid LesseeOperatingAndFinancingLeaseLiabilityToBePaid	37352000	usd
CY2022Q4	axgn	Lessee Operating And Financing Lease Liability Undiscounted Excess Amount LesseeOperatingAndFinancingLeaseLiabilityUndiscountedExcessAmount	15637000	usd
CY2022Q4	axgn	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	21715000	usd
CY2022Q4	axgn	Operating And Financing Lease Liability Current OperatingAndFinancingLeaseLiabilityCurrent	1310000	usd
CY2022Q4	axgn	Operating And Financing Lease Liability Noncurrent OperatingAndFinancingLeaseLiabilityNoncurrent	20405000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42083125	shares
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4288000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5179000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	45712000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	44821000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	6155000	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4277000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	891000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	831000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	232000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28948000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42083125	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42083125	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42083125	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41214889	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41214889	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39966937	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39966937	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42083125	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41214889	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39966937	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2022	axgn	Share Base Payment Arrangement Number Of Plans ShareBasePaymentArrangementNumberOfPlans	2	plan
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2500000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8000000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2643000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14167000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5595000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42716000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47049000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	503000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	653000	usd
CY2022Q4	axgn	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	0	usd
CY2021Q4	axgn	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	453000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	169000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	70000	usd
CY2022Q4	axgn	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	5643000	usd
CY2021Q4	axgn	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	5736000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5274000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3985000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	6357000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	6000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1174000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	-28000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	203000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	1010000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	63049000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58934000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	983000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	692000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	17000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	116000	usd
CY2022Q4	axgn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	3744000	usd
CY2021Q4	axgn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	3861000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	-4000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	4000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4740000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4673000	usd
CY2022Q4	axgn	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	58309000	usd
CY2021Q4	axgn	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	54261000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58309000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	53251000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5058000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6734000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	6357000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.051
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.073
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.071
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.016
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.006
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.175
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.247
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.277
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	42716000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd

Files In Submission

Name	View Source	Status
0000805928-23-000020-index-headers.html	Edgar Link	pending
0000805928-23-000020-index.html	Edgar Link	pending
0000805928-23-000020.txt	Edgar Link	pending
0000805928-23-000020-xbrl.zip	Edgar Link	pending
a2022consent.htm	Edgar Link	pending
axgn-20221231.htm	Edgar Link	pending
axgn-20221231.xsd	Edgar Link	pending
axgn-20221231_g1.jpg	Edgar Link	pending
axgnfy21q4ex32.htm	Edgar Link	pending
axgnfy22q4ex311.htm	Edgar Link	pending
axgnfy22q4ex312.htm	Edgar Link	pending
exhibit1023thirdamendmen.htm	Edgar Link	pending
exhibit1023thirdamendmen001.jpg	Edgar Link	pending
exhibit1023thirdamendmen002.jpg	Edgar Link	pending
exhibit1023thirdamendmen003.jpg	Edgar Link	pending
exhibit10253secondamendm.htm	Edgar Link	pending
exhibit10253secondamendm001.jpg	Edgar Link	pending
exhibit10253secondamendm002.jpg	Edgar Link	pending
exhibit10301firstamendme.htm	Edgar Link	pending
exhibit10301firstamendme001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
axgn-20221231_cal.xml	Edgar Link	unprocessable
axgn-20221231_def.xml	Edgar Link	unprocessable
axgn-20221231_lab.xml	Edgar Link	unprocessable
axgn-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
axgn-20221231_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
subsidiariesofaxogen123120.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXGN
Axogen, Inc. Stock $axgn

2023 Q1 Form 10-K Financial Statement

#000080592823000020 Filed on March 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN Axogen, Inc. Stock $axgn

2023 Q1 Form 10-K Financial Statement

#000080592823000020 Filed on March 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN
Axogen, Inc. Stock $axgn